The largest database of trusted experimental protocols

20 protocols using miglyol 812n

1

Porcine Skin for In Vitro Testing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Porcine skin, which is a recognized and representative
model for the human counterpart,13 was
used in all experiments. Dorsal skin from a single pig was obtained
from a local slaughterhouse shortly after sacrifice of the animal
and was subsequently cleaned in cold water and dermatomed (Zimmer,
Warsaw, IN) to a thickness of approximately 750 μm. The skin
sections were then individually wrapped in Parafilm and placed in
a freezer at −20 °C. Shortly before use, the skin was
thawed, and excess hair was carefully clipped using scissors. Nicotinell
Step 2 patches (GlaxoSmithKline Consumer Healthcare, UK) were acquired
from Boots UK Limited (Nottingham, UK). Zovirax (which contains 5%
w/w acyclovir) was from GlaxoSmithKline Consumer Healthcare (Brentford,
UK). Betamethasone-17-valerate (BMV, purity 100%) was purchased from
Crystal Pharma SAU (Boecillo, Spain). Eudragit RS PO (Eudragit) (ammonio
methacrylate copolymer type B) was supplied by Evonik Röhm
GmbH (Darmstadt, Germany), Klucel LF (Klucel) (hydroxypropyl cellulose)
by Azelis (Lyngby, Denmark), medium-chain triglyceride (Miglyol 812
N, caprylic/capric triglyceride) by Sasol (Hamburg, Germany), and
triethyl citrate (TEC) by Merck (Darmstadt, Germany).12 (link)
+ Open protocol
+ Expand
2

Baicalin-Loaded Nanoemulsion Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Baicalin (BN) was obtained from Shanxi Zelang Phytoextraction Co., Ltd. (Xi'an, China). Compritol 888 ATO, a hydrophobic mixture of mono-, di- and tri-behenate of glycerol, was kindly gifted by Gattefosse (Paris, France); Miglyol 812N, mixtures of Caprylic/Capric Triglycerides, was provided by Sasol (Witten, Germany); Soy lecithin was supplied by Taiwei pharmaceutical Co., Ltd. (Shanghai, China); Cremophor EL was provided by BASF (Ludwigshafen, Germany). Carboxymethyl chitosan (CMCS, Mw = 197.17 kDa) was supplied by Eisie Chemical Co., Ltd (Zhejiang, China); Poloxamer 407 (F127) was acquired from BASF (Ludwigshafen, Germany); Genipin (GP) was provided by Challenge Bioproducts (Taichung, Taiwan). Coumarin-6 (C6) was supplied by Aladdin Co., Ltd (Shanghai, China). All other reagents were of analytical grade or better.
+ Open protocol
+ Expand
3

Chitosan-based Antimicrobial Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chitosan of biomedical grade was provided by Mahtani Chitosan Pvt. Ltd., India and was the same sample used in previous studies [47] (link). The molecular weight of 115 kDa was determined by HPSEC-MALLS and the degree of acetylation of 42 % by 1 H-NMR spectroscopy. The characteristics of chitosan were selected, such that they did not inhibit the bacterial growth of the E. coli strain (unpublished); lecithin was a kind gift from Cargill (Epikuron 145 V, Cargill texturing solutions Deutschland GmbH & Co. KG, Hamburg, Germany); Miglyol 812 N was from Sasol GmbH (Witten, Germany); 3OC6HSL and all other chemicals were of analytical grade and were from Sigma-Aldrich Chemie GmbH (Hamburg, Germany).
+ Open protocol
+ Expand
4

Pea Flour-Based Emulsions with Transglutaminase

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pea flour from yellow peas (P. sativum L.) was supplied by Roquette SA (Lestrem, France). A Ca 2+ -independent microbial transglutaminase (MTGase) derived from Streptoverticillium mobaraense was obtained from Ajinomoto Foods Europe SAS, France. The commercial enzyme preparation (Activia ® WM) contains 1% active enzyme and 99% maltodextrin. The powdered preparation was assessed to have an activity of 100 U/g. The oily phase (Miglyol 812 N) was supplied by Sasol Germany Gmbh (Germany). Miglyol is a neutral, colorless, odorless and tasteless edible oil containing medium chain triglycerides. It has a high oxidation stability and remains liquid at 0 °C. Polyglycerol polyricinoleate (PGPR, Grinsted® PGPR 90, E 476) was obtained from Danisco (Denmark). PGPR is a hydrophobic emulsifier (HLB=1.5±0.5) used for the stabilization of water-in-oil emulsions. Riboflavin, vitamin B2, was supplied by Sigma Aldrich® (France). It is a water-soluble (67-333 mg/L) orange powder. All other chemicals of analytical grade were purchased to VWR International SAS (France) and Sigma-Aldrich® (France).
+ Open protocol
+ Expand
5

Formulation of Emulsified Bioactive Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
CaCl2.H2O (GR for analyses, Merck, Germany), ethanol absolute (Merck, Germany), Polyglycerol polyricinoleate (PGPR) 90 Kosher (Danisco, Denmark), Medium chain Triglycerides (MCT) (Miglyol 812 N) (Sasol, Germany), Sodium alginate extracted from brown algae (Algin, Texturas, Barcelona, Spain), β-lactoglobulin, ovalbumin and bovine serum albumin, FITC (Sigma Aldrich, Germany) were all used as received. Solutions were made in demineralized water.
+ Open protocol
+ Expand
6

Chitosan-based Quorum Sensing Inhibitor

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sample of chitosan we used was a gift from Mahtani Chitosan Pvt. Ltd., India. The molecular weight of 115000 Da was determined by HPSEC-MALLS and the degree of acetylation of 42% was determined by 1 H-NMR spectroscopy. Miglyol 812N was from Sasol GmbH (Witten, Germany); N-( -ketocaproyl)-DL-homoserine lactone (3OC6HSL), CA and all other chemicals were of analytical grade and were from Sigma-Aldrich Chemie GmbH (Hamburg, Germany).
+ Open protocol
+ Expand
7

Paclitaxel Oleate Nanoparticle Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The LDE-paclitaxel oleate preparation was made according to the methods described in
previous studies (11 (link),27 (link),28 (link)). Briefly, a lipid
mixture composed by 135 mg cholesteryl oleate (Alfa Aesar, USA), 333 mg egg
phosphatidylcholine (Lipoid, Germany), 132 mg miglyol 812N (Sasol Germany GmbH,
Germany), 6 mg cholesterol (Fabrichem, USA) and 60 mg of paclitaxel oleate
(Pharmaceuticals Co., China), was added to an aqueous phase consisting of 100 mg of
polysorbate 80 (Merck, Germany) and 10 mL Tris-HCl buffer, pH 8.05. A pre-emulsion
was obtained by ultrasonic radiation until complete solubilization of the drug.
Emulsification of all lipids, drug and aqueous phase was obtained by high-pressure
homogenization using an Emulsiflex C5 homogenizer (Avestin, Canada). After
homogenization cycles, the formed emulsion was centrifuged and the nanoparticle
sterilized by passage through 0.22 μm pore polycarbonate filter (Millipore, USA) and
kept at 4°C until used.
+ Open protocol
+ Expand
8

Lipid-Based Nanoparticle Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Miglyol 812 N (medium chain triglycerides) was supplied from Sasol GmbH (Hamburg, Germany), and soya lecithin hydrogenated (Lipoid®S75) was obtained from Lipoid GmbH (Ludwigshafen am Rhein, Germany). Polysorbate 80 (Tween®80), penicillin, streptomycin, l-glutamine, Hank’s balanced salt solution (HBSS), and Alamar blue® were obtained from Invitrogen (Alfagene Portugal), and d-α-tocopherol was obtained from Sigma-Aldrich (St. Louis, MO, USA). Ultra-purified water was obtained from Milli® Q Plus system, home supplied.
+ Open protocol
+ Expand
9

Chitosan-Coated Nanocapsules for Controlled Capsaicin Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
The chitosan-coated nanocapsules were prepared as previously described with modifications [17 ,19 ]. Briefly, for the in vitro experiments, 400 μl of a 100 mg/ml ethanolic lecithin solution (Epikuron 145 V, Cargill texturing solutions Deutschland GmbH &Co. KG, Hamburg, Germany) was mixed with 530 μl of the capsaicin stock solution (24 mg/ml). This was supplemented with 125 μl Miglyol 812 N (Sasol GmbH, Witten, Germany) and 9.5 ml ethanol. The organic solution was immediately poured into 20 ml chitosan in the aqueous phase (0.5 mg/ml in 5% stoichiometric excess of HCl). The milky mixture was concentrated in a rotavapor (Büchi R-210, Büchi Labortechnik GmbH, Essen, Germany) at 50°C until 3.5–4.0 ml remained and the volume was topped up to 4.0 ml with milliQ water if necessary to yield a final capsaicin concentration of ~10 mM. The nanoemulsions were prepared using the same procedure but without including chitosan. Unloaded nanocapsules and nanoemulsions were prepared by replacing the capsaicin solution with ethanol. The physical characteristics of the nanocapsules have been documented in a previous study [17 ]. Briefly, the size of the formulations was around 200 nm, the zeta potential was highly positive (~ +60 mV) and the polydispersity index had a value of ~ 0.2. These values were obtained by dynamic light scattering.
+ Open protocol
+ Expand
10

Chitosan-Based Nanobiomaterials for Biomedical Applications

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chitosan sample was of biomedical grade from Heppe Medical Chitosan GmbH (Halle/Saale, Germany), namely, sample Code HMC 70/5 (CAS 9012-76-04) Batch no. 212-170614-01 (degree of acetylation 32.4 % as determined by 1 H NMR; Mw ~ 29,267 g.mol -1 and Mn ~ 18,033 g.mol -1 as determined by SEC-MALS-DRI-viscosity [37] ). Soybean lecithin was from Cargill (Epikuron 145 V, Cargill GmbH, Hamburg, Germany); Miglyol ® 812N (Batch no. 151130), was donated by Sasol GmbH (Witten, Germany). Captisol ® (sulphobutyl ether-β-cyclodextrin sodium salt; SBE-β-CD) was a kind gift from CyDex, Inc_USA. NAR, 3OC6HSL and the rest of chemicals were all analytical grade and purchased from Sigma-Aldrich (Hamburg, Germany).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!